What we do
We operate as a campus of start-ups; five businesses solving the different parts of the same puzzle - meeting global demand for bioproduction.
Because it is not enough for a drug to exist. To change the world it must be accessible to everyone.
Who we are - History
Making biologics available & affordable to all through technology innovation
KEY FIGURES
- 2013 Incorporation Date
- 6 companies 1 Group with 5 affiliates
- 15.000m2 New Offices in Jumet
- 550+ Dedicated people
Latest News
New agreement paves way for development…
A year after the establishment of the mRNA Vaccine Technology Transfer Hub, Afrigen and Univercells enter a new agreement to develop the fir…
Univercells announces the acquisition of…
Jumet, Belgium, April 27, 2022 Univercells S.A., a Belgian biotech company dedicated to ensuring that everyone has access to biologics ever…
Univercells was honored by the visit of…
Univercells, a Belgian biotech company dedicated to ensuring that everyone has access to biologics everywhere in the world, was visited toda…
Prime Minister Alexander De Croo opens U…
Mr. Alexander De Croo, Prime Minister of Belgium, today formally opened a cutting-edge viral vector manufacturing facility in Jumet (Charler…
